Articles

• Linomide in relapsing and secondary progressive MSPart I: Trial design and clinical results

  J.H. Noseworthy, J.S. Wolinsky, F.D. Lublin, J.N. Whitaker, A. Linde, P. Gjorstrup, H.C. Sullivan, the North American Linomide Investigators

  • Abstract
  • Full Text
  • Full Text (PDF)
• Linomide in relapsing and secondary progressive MSPart II: MRI results

  J.S. Wolinsky, P.A. Narayana, J.H. Noseworthy, F.D. Lublin, J.N. Whitaker, A. Linde, P. Gjörstrup, H.C. Sullivan, the MRI Analysis Center of the University of Texas–Houston Health Science Center and the North American Linomide Investigators

  • Abstract
  • Full Text
  • Full Text (PDF)
• Magnetization transfer ratio in new MS lesions before and during therapy with IFNβ-1a

  M. Kita, D.E. Goodkin, P. Bacchetti, E. Waubant, S.J. Nelson, S. Majumdar

  • Abstract
  • Full Text
  • Full Text (PDF)
• The DYT1 phenotype and guidelines for diagnostic testing

  S.B. Bressman, C. Sabatti, D. Raymond, D. de Leon, C. Klein, P.L. Kramer, M.F. Brin, S. Fahn, X. Breakefield, L.J. Ozelius, N.J. Risch

  • Abstract
  • Full Text
  • Full Text (PDF)
• Decreased striatal monoaminergic terminals in Huntington disease

  N.I. Bohnen, R.A. Koeppe, P. Meyer, E. Ficaro, K. Wernette, M.R. Kilbourn, D.E. Kuhl, K.A. Frey, R.L. Albin

  • Abstract
  • Full Text
  • Full Text (PDF)
• Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD

  Y. Xu, C.R. Jack, P.C. O’Brien, E. Kokmen, G.E. Smith, R.J. Ivnik, B.F. Boeve, R.G. Tangalos, R.C. Petersen

  • Abstract
  • Full Text
  • Full Text (PDF)
• PET measures of benzodiazepine receptors in progressive supranuclear palsy

  N.L. Foster, S. Minoshima, J. Johanns, R. Little, M.L. Heumann, D.E. Kuhl, S. Gilman

  • Abstract
  • Full Text
  • Full Text (PDF)
• Predictors of progression in patients with AD and Lewy bodies

  O.L. Lopez, S. Wisniewski, R.L. Hamilton, J.T. Becker, D.I. Kaufer, S.T. DeKosky

  • Abstract
  • Full Text
  • Full Text (PDF)
• Severity of cognitive impairment and the clinical diagnosis of AD with Lewy bodies

  O.L. Lopez, R.L. Hamilton, J.T. Becker, S. Wisniewski, D.I. Kaufer, S.T. DeKosky

  • Abstract
  • Full Text
  • Full Text (PDF)
• Two brothers with frontotemporal dementia and parkinsonism with an N279K mutation of the tau gene

  K. Arima, A. Kowalska, M. Hasegawa, M. Mukoyama, R. Watanabe, M. Kawai, K. Takahashi, T. Iwatsubo, T. Tabira, N. Sunohara

  • Abstract
  • Full Text
  • Full Text (PDF)
• Atrial fibrillation and the risk of cerebral white matter lesions

  F.-E. de Leeuw, J.C. de Groot, M. Oudkerk, J.A. Kors, A. Hofman, J. van Gijn, M.M. B. Breteler

  • Abstract
  • Full Text
  • Full Text (PDF)
• Ipsilateral hemiparesis after putaminal hemorrhage due to uncrossed pyramidal tract

  H. Terakawa, K. Abe, M. Nakamura, T. Okazaki, J. Obashi, T. Yanagihara

  • Abstract
  • Full Text
  • Full Text (PDF)
• Poststroke depression and emotional incontinenceCorrelation with lesion location

  Jong S. Kim, Smi Choi-Kwon

  • Abstract
  • Full Text
  • Full Text (PDF)
• Significance of interictal bilateral temporal hypometabolism in temporal lobe epilepsy

  M. Koutroumanidis, M.J. Hennessy, P.T. Seed, R.D. C. Elwes, J. Jarosz, R.G. Morris, M.N. Maisey, C.D. Binnie, C.E. Polkey

  • Abstract
  • Full Text
  • Full Text (PDF)
• Quality of life measures in epilepsyHow well can they detect change over time?

  Gretchen L. Birbeck, Sehyun Kim, Ron D. Hays, Barbara G. Vickrey

  • Abstract
  • Full Text
  • Full Text (PDF)
• CSF insulin-like growth factor-1 in infantile neuronal ceroid lipofuscinosis

  R. Riikonen, S.-L. Vanhanen, J. Tyynelä, P. Santavuori, U. Turpeinen

  • Abstract
  • Full Text
  • Full Text (PDF)
• Oral zolmitriptan is effective in the acute treatment of cluster headache

  A. Bahra, M.J. Gawel, J.-E. Hardebo, D. Millson, S.A. Breen, P.J. Goadsby

  • Abstract
  • Full Text
  • Full Text (PDF)